SEC Form D private-offering filing

Converge Bio Inc.

Name: Converge Bio Inc. - new SEC Form D private-offering filing, Claymont, DE
Published: 2026-04-28

A new SEC Form D private-offering notice from Claymont, DE, a $25,000,000 filer-stated offering target in Biotech. The source filing is one click away.

Converge Bio Inc. site↗ Verified via SEC Form D

Develops generative AI models trained on biological data to accelerate drug discovery for pharmaceutical and biotech companies.

Filed 2026-04-28Filed to raise $25,000,000First money in 2025-09-24Raised so far $25,000,000HQ (as filed) Claymont, DESector Biotech ✓Stage (inferred) GrowthCall status Late filing

Source linked the Form D on EDGAR↗Website verified converge-bio.com↗Named in the filing 5 executives & directors

Open this row on the live feed →More new filings in Delaware →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.